Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -12.01 Million USD | -133.06% |
| 2022 | -5.15 Million USD | 75.63% |
| 2021 | -21.15 Million USD | 30.3% |
| 2020 | -30.34 Million USD | 0.04% |
| 2019 | -30.36 Million USD | -30.2% |
| 2018 | -23.31 Million USD | -41.03% |
| 2017 | -16.53 Million USD | 33.83% |
| 2016 | -24.98 Million USD | 55.05% |
| 2015 | -55.58 Million USD | -27.76% |
| 2014 | -43.51 Million USD | -180.81% |
| 2013 | -15.49 Million USD | 0.29% |
| 2012 | -15.54 Million USD | 33.07% |
| 2011 | -23.21 Million USD | -103.82% |
| 2010 | -11.39 Million USD | 2.11% |
| 2009 | -11.63 Million USD | 24.32% |
| 2008 | -15.37 Million USD | -11.32% |
| 2007 | -13.81 Million USD | -268.22% |
| 2006 | -3.75 Million USD | 4.34% |
| 2005 | -3.92 Million USD | -44.74% |
| 2004 | -2.7 Million USD | 32.39% |
| 2003 | -4 Million USD | 56.48% |
| 2002 | -9.2 Million USD | -1.8% |
| 2001 | -9.04 Million USD | -498.94% |
| 2000 | -1.51 Million USD | 24.5% |
| 1999 | -2 Million USD | -53.85% |
| 1998 | -1.3 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 10.52 Million USD | 187.57% |
| 2024 Q3 | 9.15 Million USD | 1350.4% |
| 2024 Q2 | 631 Thousand USD | -94.0% |
| 2023 Q3 | -11.12 Million USD | -209.85% |
| 2023 Q4 | -12.01 Million USD | -8.04% |
| 2023 FY | -12.01 Million USD | -133.06% |
| 2023 Q1 | 4.09 Million USD | 179.38% |
| 2023 Q2 | 10.12 Million USD | 147.39% |
| 2022 Q1 | -12.71 Million USD | 39.87% |
| 2022 Q2 | -9.65 Million USD | 24.13% |
| 2022 Q3 | -5.07 Million USD | 47.43% |
| 2022 Q4 | -5.15 Million USD | -1.62% |
| 2022 FY | -5.15 Million USD | 75.63% |
| 2021 Q1 | -35.29 Million USD | -16.31% |
| 2021 FY | -21.15 Million USD | 30.3% |
| 2021 Q2 | -47.69 Million USD | -35.12% |
| 2021 Q4 | -21.15 Million USD | 65.7% |
| 2021 Q3 | -61.66 Million USD | -29.29% |
| 2020 Q3 | -35.98 Million USD | -142.28% |
| 2020 Q2 | -14.85 Million USD | -74.06% |
| 2020 Q1 | -8.53 Million USD | 71.89% |
| 2020 FY | -30.34 Million USD | 0.04% |
| 2020 Q4 | -30.34 Million USD | 15.67% |
| 2019 Q3 | -28.91 Million USD | -28.69% |
| 2019 FY | -30.36 Million USD | -30.2% |
| 2019 Q2 | -22.47 Million USD | -56.02% |
| 2019 Q1 | -14.4 Million USD | 38.24% |
| 2019 Q4 | -30.36 Million USD | -5.0% |
| 2018 Q2 | -27.71 Million USD | -28.32% |
| 2018 Q4 | -23.31 Million USD | 14.5% |
| 2018 FY | -23.31 Million USD | -41.03% |
| 2018 Q1 | -21.59 Million USD | -30.62% |
| 2018 Q3 | -27.27 Million USD | 1.58% |
| 2017 Q3 | -11.35 Million USD | -0.81% |
| 2017 FY | -16.53 Million USD | 33.83% |
| 2017 Q4 | -16.53 Million USD | -45.67% |
| 2017 Q2 | -11.25 Million USD | 36.22% |
| 2017 Q1 | -17.65 Million USD | 29.35% |
| 2016 Q3 | -34.65 Million USD | 11.11% |
| 2016 FY | -24.98 Million USD | 55.05% |
| 2016 Q2 | -38.98 Million USD | 8.62% |
| 2016 Q1 | -42.66 Million USD | 23.24% |
| 2016 Q4 | -24.98 Million USD | 27.9% |
| 2015 Q1 | -26.56 Million USD | 38.96% |
| 2015 Q2 | -30.01 Million USD | -13.01% |
| 2015 Q4 | -55.58 Million USD | -2.74% |
| 2015 Q3 | -54.1 Million USD | -80.27% |
| 2015 FY | -55.58 Million USD | -27.76% |
| 2014 Q4 | -43.51 Million USD | -9.52% |
| 2014 Q1 | -10.51 Million USD | 32.13% |
| 2014 Q2 | -8.44 Million USD | 19.7% |
| 2014 Q3 | -39.72 Million USD | -370.5% |
| 2014 FY | -43.51 Million USD | -180.81% |
| 2013 Q4 | -15.49 Million USD | 12.51% |
| 2013 Q3 | -17.71 Million USD | 13.76% |
| 2013 Q1 | -21.46 Million USD | -38.13% |
| 2013 Q2 | -20.53 Million USD | 4.32% |
| 2013 FY | -15.49 Million USD | 0.29% |
| 2012 Q1 | -62.92 Million USD | -171.03% |
| 2012 FY | -15.54 Million USD | 33.07% |
| 2012 Q3 | -65.86 Million USD | 10.49% |
| 2012 Q2 | -73.58 Million USD | -16.95% |
| 2012 Q4 | -15.54 Million USD | 76.41% |
| 2011 FY | -23.21 Million USD | -103.82% |
| 2011 Q1 | -14.3 Million USD | -25.62% |
| 2011 Q2 | -15.49 Million USD | -8.28% |
| 2011 Q3 | -18.43 Million USD | -18.99% |
| 2011 Q4 | -23.21 Million USD | -25.93% |
| 2010 Q4 | -11.39 Million USD | -32.19% |
| 2010 Q3 | -8.61 Million USD | 22.88% |
| 2010 Q2 | -11.17 Million USD | -0.4% |
| 2010 Q1 | -11.12 Million USD | 4.36% |
| 2010 FY | -11.39 Million USD | 2.11% |
| 2009 Q3 | -5.74 Million USD | -3.83% |
| 2009 FY | -11.63 Million USD | 24.32% |
| 2009 Q1 | -11.96 Million USD | 22.16% |
| 2009 Q2 | -5.53 Million USD | 53.78% |
| 2009 Q4 | -11.63 Million USD | -102.58% |
| 2008 Q2 | -26.74 Million USD | -78.33% |
| 2008 FY | -15.37 Million USD | -11.32% |
| 2008 Q4 | -15.37 Million USD | -12.58% |
| 2008 Q3 | -13.65 Million USD | 48.93% |
| 2008 Q1 | -14.99 Million USD | -8.59% |
| 2007 Q2 | -6.02 Million USD | -2484.55% |
| 2007 Q4 | -13.81 Million USD | -248.79% |
| 2007 Q1 | -233 Thousand USD | 93.79% |
| 2007 Q3 | -3.96 Million USD | 34.24% |
| 2007 FY | -13.81 Million USD | -268.22% |
| 2006 Q3 | -870 Thousand USD | 44.94% |
| 2006 Q4 | -3.75 Million USD | -331.15% |
| 2006 Q2 | -1.58 Million USD | 12.42% |
| 2006 Q1 | -1.8 Million USD | 53.99% |
| 2006 FY | -3.75 Million USD | 4.34% |
| 2005 Q2 | -974 Thousand USD | 52.63% |
| 2005 Q1 | -2.05 Million USD | 24.1% |
| 2005 FY | -3.92 Million USD | -44.74% |
| 2005 Q4 | -3.92 Million USD | 21.28% |
| 2005 Q3 | -4.98 Million USD | -411.4% |
| 2004 Q3 | -12.42 Million USD | -91.45% |
| 2004 FY | -2.7 Million USD | 32.39% |
| 2004 Q4 | -2.7 Million USD | 78.2% |
| 2004 Q1 | -7.96 Million USD | -98.78% |
| 2004 Q2 | -6.49 Million USD | 18.49% |
| 2003 FY | -4 Million USD | 56.48% |
| 2003 Q3 | -5.25 Million USD | 0.02% |
| 2003 Q2 | -5.25 Million USD | 49.04% |
| 2003 Q1 | -10.31 Million USD | -12.06% |
| 2003 Q4 | -4 Million USD | 23.78% |
| 2002 Q2 | -3.79 Million USD | -86.24% |
| 2002 Q1 | -2.03 Million USD | 77.5% |
| 2002 Q4 | -9.2 Million USD | -44.02% |
| 2002 Q3 | -6.39 Million USD | -68.68% |
| 2002 FY | -9.2 Million USD | -1.8% |
| 2001 Q3 | -4.68 Million USD | -13.13% |
| 2001 Q4 | -9.04 Million USD | -92.96% |
| 2001 FY | -9.04 Million USD | -498.94% |
| 2001 Q2 | -4.14 Million USD | -183.57% |
| 2001 Q1 | -1.46 Million USD | 3.25% |
| 2000 Q4 | -1.51 Million USD | -25.73% |
| 2000 Q2 | -2.64 Million USD | -46.67% |
| 2000 FY | -1.51 Million USD | 24.5% |
| 2000 Q1 | -1.8 Million USD | 10.0% |
| 2000 Q3 | -1.2 Million USD | 54.51% |
| 1999 Q4 | -2 Million USD | -81.82% |
| 1999 Q1 | -1 Million USD | 23.08% |
| 1999 Q3 | -1.1 Million USD | 8.33% |
| 1999 Q2 | -1.2 Million USD | -20.0% |
| 1999 FY | -2 Million USD | -53.85% |
| 1998 Q3 | -1.8 Million USD | 89.47% |
| 1998 FY | -1.3 Million USD | 0.0% |
| 1998 Q2 | -17.1 Million USD | 0.0% |
| 1998 Q4 | -1.3 Million USD | 27.78% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 144.362% |
| BrainsWay Ltd. | -10.32 Million USD | -16.415% |
| Cerus Corporation | 84.35 Million USD | 114.243% |
| Envoy Medical, Inc. | -3.81 Million USD | -214.997% |
| electroCore, Inc. | -9.95 Million USD | -20.683% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -134.42% |
| IceCure Medical Ltd | -9.93 Million USD | -20.938% |
| Inogen, Inc. | -103.56 Million USD | 88.4% |
| OrthoPediatrics Corp. | -9.26 Million USD | -29.643% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -229.964% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 8.269% |
| MaxCyte, Inc. | -27.76 Million USD | 56.727% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -133.822% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1986.608% |
| Orthofix Medical Inc. | 96.44 Million USD | 112.457% |
| PAVmed Inc | 29.08 Million USD | 141.305% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 29.075% |
| RxSight, Inc. | -6.68 Million USD | -79.85% |
| Sight Sciences, Inc. | -102.71 Million USD | 88.304% |
| SI-BONE, Inc. | 5.72 Million USD | 309.998% |
| TELA Bio, Inc. | -3.94 Million USD | -204.229% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 120.959% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 3513.068% |
| Acutus Medical, Inc. | 12.27 Million USD | 197.842% |
| Talis Biomedical Corporation | -57.06 Million USD | 78.946% |
| Spectral AI, Inc. | -3.5 Million USD | -243.159% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 74.985% |
| CVRx, Inc. | -59.95 Million USD | 79.962% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 705.5% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 1040.33% |
| Bioventus Inc. | 372.51 Million USD | 103.225% |
| Venus Concept Inc. | 74.3 Million USD | 116.169% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -17.993% |
| LivaNova PLC | 62.53 Million USD | 119.213% |
| 908 Devices Inc. | -115.09 Million USD | 89.562% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 103.746% |
| Nemaura Medical Inc. | 9.92 Million USD | 221.048% |
| NeuroPace, Inc. | 54.33 Million USD | 122.11% |
| LENSAR, Inc. | -18.31 Million USD | 34.393% |
| Apyx Medical Corporation | -5.15 Million USD | -133.236% |
| Cutera, Inc. | 288.3 Million USD | 104.167% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 259.867% |
| BioSig Technologies, Inc. | 262 Thousand USD | 4685.496% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 72.59% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -30.601% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.855% |
| Axonics, Inc. | -77.19 Million USD | 84.437% |
| Outset Medical, Inc. | 67.67 Million USD | 117.751% |
| IRIDEX Corporation | -4.28 Million USD | -180.177% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 93.251% |
| IRadimed Corporation | -47.71 Million USD | 74.824% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -297.026% |
| INVO Bioscience, Inc. | 8.45 Million USD | 242.158% |
| Telesis Bio, Inc. | 32.63 Million USD | 136.813% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -380.151% |
| Varex Imaging Corporation | 316.9 Million USD | 103.791% |
| Quipt Home Medical Corp. | 81.73 Million USD | 114.699% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -331.848% |
| Pulmonx Corporation | -42.36 Million USD | 71.638% |
| Dynatronics Corporation | 6.2 Million USD | 293.648% |
| Modular Medical, Inc. | -8.04 Million USD | -49.391% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -179.59% |
| Semler Scientific, Inc. | -57.13 Million USD | 78.971% |
| InMode Ltd. | -135.39 Million USD | 91.127% |
| Bruker Corporation | 891.3 Million USD | 101.348% |
| Cytosorbents Corporation | 4.18 Million USD | 387.278% |
| DexCom, Inc. | 2.02 Billion USD | 100.592% |
| Align Technology, Inc. | -840.47 Million USD | 98.571% |
| Viveve Medical, Inc. | -13.81 Million USD | 13.024% |
| ZimVie Inc. | 450.41 Million USD | 102.667% |
| Movano Inc. | -5.86 Million USD | -104.807% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 91.065% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1986.608% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 705.5% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 103.367% |
| Profound Medical Corp. | -18.17 Million USD | 33.911% |
| Insulet Corporation | 798.1 Million USD | 101.505% |
| enVVeno Medical Corporation | -2.21 Million USD | -441.659% |
| iCAD, Inc. | -21.2 Million USD | 43.354% |
| Nuwellis, Inc. | -2.81 Million USD | -326.179% |
| Biotricity, Inc. | 23.09 Million USD | 152.025% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 112.828% |
| Aethlon Medical, Inc. | -4.5 Million USD | -166.879% |
| InspireMD, Inc. | -8.04 Million USD | -49.335% |
| PAVmed Inc. | 29.08 Million USD | 141.305% |
| BIOLASE, Inc. | 11.34 Million USD | 205.906% |
| Beyond Air, Inc. | 6.22 Million USD | 292.872% |
| FONAR Corporation | -14.66 Million USD | 18.079% |
| AxoGen, Inc. | 32.26 Million USD | 137.234% |
| Vivani Medical, Inc. | 42 Thousand USD | 28704.762% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -12.723% |
| Inari Medical, Inc. | -7.16 Million USD | -67.77% |
| UFP Technologies, Inc. | 40.77 Million USD | 129.465% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 491.511% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -151.797% |
| Tenon Medical, Inc. | -1.25 Million USD | -857.291% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -57.954% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -0.735% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.542% |
| Sintx Technologies, Inc. | 905 Thousand USD | 1427.514% |
| NanoVibronix, Inc. | -3.27 Million USD | -266.504% |
| Quanterix Corporation | -132.95 Million USD | 90.964% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -331.848% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 46.282% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.594% |
| TransMedics Group, Inc. | 121.13 Million USD | 109.918% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 54.11% |
| NeuroMetrix, Inc. | -1.49 Million USD | -705.73% |
| Hyperfine, Inc. | -75.61 Million USD | 84.112% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 107.894% |
| Biomerica, Inc. | -3.38 Million USD | -254.919% |
| Bone Biologics Corporation | -3.02 Million USD | -296.951% |
| AVITA Medical, Inc. | -26.23 Million USD | 54.2% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -553.499% |
| Silk Road Medical, Inc | 64.42 Million USD | 118.649% |